Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant

Clinical Infectious Diseases

Volumn 35, Issue 9, 2002, Pages 1027-1031

  Papadogiannakis, Nikos ^a   Tolfvenstam, Thomas ^a   Fischler, Björn ^a   Norbeck, Oscar ^a   Broliden, Kristina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; ASTHMA; AUTOPSY; CASE REPORT; CLINICAL FEATURE; FEMALE; HEART; HEART ARREST; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; INFANT DISEASE; KIDNEY; LIVER; LUNG; PARVOVIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SPLEEN; SUDDEN DEATH; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS DETECTION; VIRUS MYOCARDITIS;

DNA, VIRAL; FEMALE; HUMANS; INFANT; MYOCARDITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION;

EID: 0036827584     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342574     Document Type: Article

References (29)

1. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr 1999;46:245-69.
2. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
3. Ni J, Bowles NE, Kim Y-H, et al. Viral infection of the myocardium in endocardial fibroelastosis: Molecular evidence for the role of mumps virus as an etiologic agent. Circulation 1997;95:133-9.
4. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: Diagnosis using the polymerase chain reaction. Circulation 1997;96:3549-54.
5. Bowles NE, Kearney DL, Ni J, et al. The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol 1999;34:857-65.
6. Barton Rogers B. Parvovirus B19: Twenty-five years in perspective. Pediatr Dev Pathol 1999;2:296-315.
7. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988;1:535-6.
8. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989;9:105-114.
9. Beghetti M, Gervaix A, Haenggeli CA, Berner M, Rimensberger PC. Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy. Eur J Pediatr 2000;159:135-6.
10. Borreda D, Palomera S, Gilbert B, Lienhardt A, de Lumley L. 24 Cases of human parvovirus B19 infection in children [in French]. Ann Pediatr (Paris) 1992;39:543-9.
11. Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 2001;32:342-5.
12. Nigro G, Bastianon V, Colloridi V, et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: Report of 3 cases and review. Clin Infect Dis 2000;31:65-9.
13. Saint-Martin J, Choulot JJ, Bonnaud E, Morinet F. Myocarditis caused by parvovirus. J Pediatr 1990;116:1007-8.
14. van Wees J, Stiller B, Berger F, et al. Chronic persistent parvovirus B19 myocarditis in childhood [in German]. Monatsschr Kinderheilkd 1999;8:748-50.
15. Tolfvenstam T, Papadogiannakis N, Norbeck O, Pettersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357:1494-7.
16. + T-lymphocytes infiltrate the myocardium in fulminant herpes virus myocarditis. Pediatr Pathol Mol Med 2001;20:189-95.
17. + T-lymphocyte responses to human parvovirus B19. J Virol 2001;75:540-3.
18. Broliden K, Tolfvenstam T, Ohlsson S, Henter JI. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr Oncol 1998;31:66-72.
19. Flunker G, Peters A, Wiersbitzky S, Modrow S, Seidel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol (Berl) 1998;186:189-94.
20. Weigel-Kelley KA, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001;75:4110-6.
21. Jordan JA, DeLoia JA. Globoside expression within the human placenta. Placenta 1999;20:103-8.
22. Soulié JC. Cardiac involvement in fetal parvovirus B19 infection [in French]. Pathol Biol (Paris) 1995;43:416-9.
23. Chia JKS, Jackson B. Myopericarditis due to parvovirus B19 in an adult. Clin Infect Dis 1996;23:200-1.
24. Orth T, Herr W, Spahn T, et al. Human parvovirus B19 infection associated with severe acute perimyocarditis in a 34-year-old man. Eur Heart J 1997;18:524-5.
25. Tsuda H, Maeda Y, Nakagawa M, et al. Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia. Br J Haematol 1994;86:413-4.
26. Enders G, Dötsch J, Bauer J, et al. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: Two case reports. Clin Infect Dis 1998;26:355-8.
27. Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 2001;39:4585-7.
28. Eck M, Greiner A, Kandolf R, Schmaußer B, Marx A, Müller-Hermelink HK. Active fulminant myocarditis characterized by T-lymphocytes expressing the gamma-delta T-cell receptor: A new disease entity? Am J Surg Pathol 1997;21:1109-12.
29. Go RO, Martin TR, Lester MR. A wheezy infant unresponsive to bronchodilators. Ann Allergy Asthma Immunol 1997;78:449-56.